← Evidence map

ReviewFrontiers in oncology2021

Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future Perspectives.

Huimei Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

29 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34094935